Rafael J Tamargo1, Arash Velayati, Ehud Goldin, Ellen Sidransky. 1. Section on Molecular Neurogenetics, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892-3708, USA. tamargorj@mail.nih.gov
Abstract
Saposin C is one of four homologous proteins derived from sequential cleavage of the saposin precursor protein, prosaposin. It is an essential activator for glucocerebrosidase, the enzyme deficient in Gaucher disease. Gaucher disease is a rare autosomal recessive lysosomal storage disorder caused by mutations in the GBA gene that exhibits vast phenotypic heterogeneity, despite its designation as a "simple" Mendelian disorder. The observed phenotypic variability has led to a search for disease modifiers that can alter the Gaucher phenotype. The PSAP gene encoding saposin C is a prime candidate modifier for Gaucher disease. In humans, saposin C deficiency due to mutations in PSAP results in a Gaucher-like phenotype, despite normal in vitro glucocerebrosidase activity. Saposin C deficiency has also been shown to modify phenotype in one mouse model of Gaucher disease. The role of saposin C as an activator required for normal glucocerebrosidase function, and the consequences of saposin C deficiency are described, and are being explored as potential modifying factors in patients with Gaucher disease. Published by Elsevier Inc.
Saposin C is one of four homologous proteins n class="Chemical">derived from sequential cleavage of the saposin precursor protein, prosaposin. It is an essential activator for glucocerebrosidase, the enzyme deficient in Gaucher disease. Gaucher disease is a rare autosomal recessive lysosomal storage disorder caused by mutations in the GBA gene that exhibits vast phenotypic heterogeneity, despite its designation as a "simple" Mendelian disorder. The observed phenotypic variability has led to a search for disease modifiers that can alter the Gaucher phenotype. The PSAP gene encoding saposin C is a prime candidate modifier for Gaucher disease. In humans, saposinC deficiencydue to mutations in PSAP results in a Gaucher-like phenotype, despite normal in vitro glucocerebrosidase activity. SaposinC deficiency has also been shown to modify phenotype in one mouse model of Gaucher disease. The role of saposin C as an activator required for normal glucocerebrosidase function, and the consequences of saposinC deficiency are described, and are being explored as potential modifying factors in patients with Gaucher disease. Published by Elsevier Inc.
Authors: Richard A Steet; Stephen Chung; Brandon Wustman; Allan Powe; Hung Do; Stuart A Kornfeld Journal: Proc Natl Acad Sci U S A Date: 2006-08-31 Impact factor: 11.205
Authors: Benjamin Liou; Andrzej Kazimierczuk; Min Zhang; C Ronald Scott; Rashmi S Hegde; Gregory A Grabowski Journal: J Biol Chem Date: 2005-11-17 Impact factor: 5.157
Authors: A Tylki-Szymańska; B Czartoryska; M-T Vanier; B J M H Poorthuis; J A E Groener; A Ługowska; G Millat; A M Vaccaro; E Jurkiewicz Journal: Clin Genet Date: 2007-10-07 Impact factor: 4.438
Authors: Navin Rauniyar; Kanagaraj Subramanian; Mathieu Lavallée-Adam; Salvador Martínez-Bartolomé; William E Balch; John R Yates Journal: Mol Cell Proteomics Date: 2015-04-14 Impact factor: 5.911
Authors: Raquel Romero; Arvind Ramanathan; Tony Yuen; Debsindhu Bhowmik; Mehr Mathew; Lubna Bashir Munshi; Seher Javaid; Madison Bloch; Daria Lizneva; Alina Rahimova; Ayesha Khan; Charit Taneja; Se-Min Kim; Li Sun; Maria I New; Shozeb Haider; Mone Zaidi Journal: Proc Natl Acad Sci U S A Date: 2019-02-26 Impact factor: 11.205
Authors: Marina Siebert; Wendy Westbroek; Yu-Chi Chen; Nima Moaven; Yan Li; Arash Velayati; Maria Luiza Saraiva-Pereira; Scott E Martin; Ellen Sidransky Journal: RNA Biol Date: 2014 Impact factor: 4.652
Authors: Bouchra Ouled Amar Bencheikh; Etienne Leveille; Jennifer A Ruskey; Dan Spiegelman; Christopher Liong; Edward A Fon; Guy A Rouleau; Yves Dauvilliers; Nicolas Dupre; Roy N Alcalay; Ziv Gan-Or Journal: Neurobiol Aging Date: 2018-07-02 Impact factor: 4.673